These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2431765)
1. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Nagle RB; Ahmann FR; McDaniel KM; Paquin ML; Clark VA; Celniker A Cancer Res; 1987 Jan; 47(1):281-6. PubMed ID: 2431765 [TBL] [Abstract][Full Text] [Related]
2. Keratin immunoreactivity in the benign and neoplastic human prostate. Brawer MK; Peehl DM; Stamey TA; Bostwick DG Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099 [TBL] [Abstract][Full Text] [Related]
3. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957 [TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
5. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417 [TBL] [Abstract][Full Text] [Related]
7. Keratin patterns in prostatic hyperplasia and adenocarcinoma. Svanholm H; Nielsen B; Starklint H APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH; Signoretti S; Loda M Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011 [TBL] [Abstract][Full Text] [Related]
9. Expression of basal cell keratins in human prostate cancer metastases and cell lines. van Leenders GJ; Aalders TW; Hulsbergen-van de Kaa CA; Ruiter DJ; Schalken JA J Pathol; 2001 Dec; 195(5):563-70. PubMed ID: 11745692 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis of prostate carcinoma on biopsy specimens improved by basal-cell-specific anti-cytokeratin antibody (34 beta E12). Freibauer C Wien Klin Wochenschr; 1998 Sep; 110(17):608-11. PubMed ID: 9816630 [TBL] [Abstract][Full Text] [Related]
11. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
12. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry. Helpap B; Köllermann J; Oehler U J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415 [TBL] [Abstract][Full Text] [Related]
13. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Ruiz M; Troncoso P; Bruns C; Bar-Eli M Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506 [TBL] [Abstract][Full Text] [Related]
14. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851 [TBL] [Abstract][Full Text] [Related]
15. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related]
16. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma. Hussein MR; Al-Assiri M; Musalam AO Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537 [TBL] [Abstract][Full Text] [Related]
18. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Webber MM; Bello D; Quader S Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636 [TBL] [Abstract][Full Text] [Related]
19. Changes in keratin expression during the development of benign prostatic hyperplasia. Xue Y; Smedts F; Umbas R; Aalders TW; Debruyne FM; de la Rosette JJ; Schalken JA Eur Urol; 1997; 32(3):332-8. PubMed ID: 9358223 [TBL] [Abstract][Full Text] [Related]
20. [Suspicious acinar proliferations of the prostate]. Helpap B Verh Dtsch Ges Pathol; 1999; 83():162-7. PubMed ID: 10714207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]